Abstract:The DNA binding and cross-linking modes of a trinuclear platinum Complex [Pt3Cl3(hptab)][ClO4](3) (1; hptab = N,N,N',N',N '',N ''-hexakis(2-pyridylmethyl)-1,3,5-tris(aminomethyl)benzene) and its dinuclear analogue [Pt2Cl2(m-tpxa)]Cl-2 (2; m-tpxa = N,N,N',N'-tetra(2-pyridylmethyl)-m-xylylene diamine) are reported and compared. The adducts of 1 and 2 with 18-mer duplex N1, 5'-d(GAAGAAGTCA-CAAAATGT)-3'center dot 5'-d(ACATTTTGT-GACTTCTTC)-3', have been characterized by means of denaturing polyacrylamide gels, Maxam-Gilbert sequencing, and MALDI-TOF mass spectrometry combined with enzymatic degradation to obtain insights into Structural features responsible for the differences in their antitumor activities. The cytotoxic-active complex 1 readily forms various DNA adducts, such as through 1,3- and 1,4-intrastrand cross-links, and in particular, the unique and unprecedented interstrand cross-linked triadducts. In contrast, the cytotoxic-inactive complex 2 preferentially forms 1,4-intrastrand rather than 1,3-intra- and -interstrand cross-links. Digestion of the DNA adducts of 1 shows that the cleavage is completely blocked at one nucleotide before the cross-linked guanine residues on the opposite strand, a feature that appears to be unprecedented in antitumor platinum complexes. In the case of 2, the cleavage bypasses the first platinated guanine site and stops at one nucleotide prior to the second platinated site, confirming that very few 1,3-intrastrand cross-links are formed by 2. These results are supported by molecular-modeling studies of intra- and interstrand cross-links Of duplex NI with 1 and 2. The remarkable differences between 1 and 2 in DNA binding and cross-linking provide mechanistic insights into their different cytotoxicity against the tumor cell lines; these insights are useful for designing future antitumor agents.

DNA topoisomerases as additional targets for anticancer monofunctional platinum( ii ) complexes

Platinum complexes as inhibitors of DNA repair protein Ku70 and topoisomerase IIα in cancer cells

Platinum complexes as inhibitors of DNA repair protein Ku70 and topoisomerase II in cancer cells

Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance.

Molecular Mechanisms of Chemoresistance and Cytotoxicity Associated with Platinum Drugs

Enhancing Cytotoxicity of a Monofunctional Platinum Complex Via a Dual-DNA-Damage Approach.

Synthesis and biological evaluation of new mono naphthalimide platinum(IV) derivatives as antitumor agents with dual DNA damage mechanism

Antitumor Active Monofunctional Platinum(ii) Complexes: Synthesis, Structural Characterization and Reactivity Towards Biomolecules

Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand

Fresh platinum complexes with promising antitumor activity.

Dna Cross-Linking Patterns Induced by an Antitumor-Active Trinuclear Platinum Complex and Comparison with Its Dinuclear Analogue

Synthesis and DNA Interactions Study of Novel Fluorinated Pyridinium Platinum (IV) Complexes with Tumor Targeting Activity

Dual-target platinum(IV) complexes exhibit antiproliferative activity through DNA damage and induce ER-stress-mediated apoptosis in A549 cells

DNA-Unresponsive Platinum(II) Complex Induces ERS-Mediated Mitophagy in Cancer Cells

Unique Dna Binding Mode Of Antitumor Trinuclear Tridentate Platinum(Ii) Compound

Platinum(ii) Clovers Targeting G-quadruplexes and Their Anticancer Activities

Metal complexes as photochemical nitric oxide precursors : Potential applications in the treatment of tumors

Synthesis and Biological Evaluation of Xanthone Derivatives As Anti-Cancer Agents Targeting Topoisomerase II and DNA

A Dinuclear Monofunctional Platinum(ii) Complex with an Aromatic Linker Shows Low Reactivity Towards Glutathione but High DNA Binding Ability and Antitumor Activity

Ruthenium(II) complexes as mitochondrial inhibitors of topoisomerase induced A549 cell apoptosis

A monofunctional trinuclear platinum complex with steric hindrance demonstrates strong cytotoxicity against tumor cells.